Skip to content

GENEREX, DOCTEUR ANDRE DELFORGE: what changed

What changed

GENEREX, DOCTEUR ANDRE DELFORGE

BE 0477.025.511
NACE 86.910, Medical imaging and medical laboratories
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€140,660
2024 · €157,339-€16,679
Equity
€1.3m
2024 · €1.4m-€69,866
Cash
€104,298
2024 · €136,073-€31,775
Balance sheet total
€1.5m
2024 · €1.5m+€9,342

Largest movements

2024 to 2025
Assets
  • Current investments +€65,948

    up €65,948 (+5.2%), from €1.3m to €1.3m

  • Cash -€31,775

    down €31,775 (-23.4%), from €136,073 to €104,298

    mainly Contributions, distributions and other (-€210,526) and Current investments (-€65,948)

  • Tangible fixed assets -€17,278

    down €17,278 (-18.9%), from €91,249 to €73,971

    of which Furniture and vehicles: -€16,700

Equity and liabilities
  • Reserves -€69,866

    down €69,866 (-5.1%), from €1.4m to €1.3m

  • Advances received +€64,750

    up €64,750 (+70.1%), from €92,310 to €157,060

  • Other debts +€38,598

    up €38,598 (+529%), from €7,297 to €45,895

  • Tax, wage and social debts -€22,758

    down €22,758 (-71.7%), from €31,742 to €8,984

Income statement
  • Gross operating margin -€21,353

    down €21,353 (-9.0%), from €237,190 to €215,837

  • Taxes -€5,399

    down €5,399 (-7.3%), from €74,045 to €68,646

  • Other operating charges -€4,900

    down €4,900 (-83.8%), from €5,850 to €950

  • Financial income -€4,195

    down €4,195 (-19.9%), from €21,108 to €16,914

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €157,339
Gross operating margin -€21,353
Depreciation -€1,474
Other operating charges +€4,900
Financial income -€4,195
Financial charges +€44
Taxes +€5,399
Result 2025 €140,660
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€248,828
Investment -€70,077
Financing -€210,526
Cash 2024 €136,073
Net result for the year +€140,660
Depreciation +€21,407
Receivables within one year +€6,477
Deferred charges and accrued income +€1,075
Trade debts -€1,382
Tax, wage and social debts -€22,758
Advances received +€64,750
Other debts +€38,598
Accrued charges and deferred income +€1
Investment in fixed assets (net) -€4,129
Current investments -€65,948
Contributions, distributions and other -€210,526
Cash 2025 €104,298
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,522,833 €1,532,175 +€9,342 +0.6%
Fixed assets 21/28 €91,499 €74,221 -€17,278 -18.9%
Tangible fixed assets 22/27 €91,249 €73,971 -€17,278 -18.9%
Plant, machinery and equipment 23 €2,331 €5,145 +€2,814 +121%
Furniture and vehicles 24 €60,038 €43,338 -€16,700 -27.8%
Other tangible fixed assets 26 €28,880 €25,488 -€3,392 -11.7%
Financial fixed assets 28 €250 €250 = 0.0%
Current assets 29/58 €1,431,333 €1,457,954 +€26,621 +1.9%
Amounts receivable within one year 40/41 €16,167 €9,690 -€6,477 -40.1%
Trade receivables 40 €16,167 €9,690 -€6,477 -40.1%
Other amounts receivable 41 €0 - =
Current investments 50/53 €1,275,492 €1,341,440 +€65,948 +5.2%
Cash at bank and in hand 54/58 €136,073 €104,298 -€31,775 -23.4%
Deferred charges and accrued income 490/1 €3,601 €2,526 -€1,075 -29.9%
Total equity and liabilities 10/49 €1,522,833 €1,532,175 +€9,342 +0.6%
Equity 10/15 €1,385,088 €1,315,222 -€69,866 -5.0%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €1,372,679 €1,302,813 -€69,866 -5.1%
Distributable reserves 133 €1,372,679 €1,302,813 -€69,866 -5.1%
Profit (loss) carried forward 14 €9 €9 = 0.0%
Amounts payable 17/49 €137,744 €216,953 +€79,209 +57.5%
Amounts payable within one year 42/48 €137,699 €216,907 +€79,208 +57.5%
Trade debts 44 €6,350 €4,968 -€1,382 -21.8%
Suppliers 440/4 €6,350 €4,968 -€1,382 -21.8%
Advances received on contracts in progress 46 €92,310 €157,060 +€64,750 +70.1%
Taxes, remuneration and social security 45 €31,742 €8,984 -€22,758 -71.7%
Taxes 450/3 €31,742 €8,984 -€22,758 -71.7%
Other amounts payable 47/48 €7,297 €45,895 +€38,598 +529%
Accrued charges and deferred income 492/3 €45 €46 +€1 +2.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €19,933 €21,407 +€1,474 +7.4%
Other operating charges 640/8 €5,850 €950 -€4,900 -83.8%
Gross operating margin 9900 €237,190 €215,837 -€21,353 -9.0%
Operating profit (loss) 9901 €211,407 €193,480 -€17,927 -8.5%
Financial income 75/76B €21,108 €16,914 -€4,195 -19.9%
Recurring financial income 75 €21,108 €16,914 -€4,195 -19.9%
Financial charges 65/66B €1,131 €1,088 -€44 -3.9%
Recurring financial charges 65 €1,131 €1,088 -€44 -3.9%
Profit (loss) for the period before taxes 9903 €231,384 €209,306 -€22,078 -9.5%
Income taxes 67/77 €74,045 €68,646 -€5,399 -7.3%
Profit (loss) for the period 9904 €157,339 €140,660 -€16,679 -10.6%
Profit (loss) for the period to be appropriated 9905 €157,339 €140,660 -€16,679 -10.6%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.